Skip to main content
Erschienen in: Journal of Nuclear Cardiology 6/2017

01.12.2017 | Original Article

Prognostic significance of blood pressure response during vasodilator stress Rb-82 positron emission tomography myocardial perfusion imaging

verfasst von: Bradley Witbrodt, MD, Abhinav Goyal, MD, MHS, Anita A. Kelkar, MD, Sharmila Dorbala, MD, MPH, Benjamin J. W. Chow, MD, Marcelo F. Di Carli, MD, Brent A. Williams, PhD, Michael E. Merhige, MD, Daniel S. Berman, MD, Guido Germano, PhD, Robert S. Beanlands, MD, James K. Min, MD, Punitha Arasaratnam, MD, Masoud Sadreddini, MD, Marjolein Lidwine van Velthuijsen, MD, Leslee J. Shaw, PhD

Erschienen in: Journal of Nuclear Cardiology | Ausgabe 6/2017

Einloggen, um Zugang zu erhalten

Abstract

Background

A drop in blood pressure (BP) or blunted BP response is an established high-risk marker during exercise myocardial perfusion imaging (MPI); however, data are sparse regarding the prognostic value of BP response in patients undergoing vasodilator stress rubidium-82 (Rb-82) Positron Emission Tomography (PET) MPI.

Methods and Results

From the PET Prognosis Multicenter Registry, a cohort of 3413 patients underwent vasodilator stress Rb-82 PET MPI with dipyridamole or adenosine. We used multivariable Cox proportional hazard regression to analyze the association with mortality of four BP variables: stress minus rest systolic BP (∆SBP), stress minus rest diastolic BP (∆DBP), resting systolic BP (rSBP), and resting diastolic BP (rDBP). Covariates that had univariate P values <.10 were entered into the multivariable model. After median 1.7 years follow-up, 270 patients died. In univariate analyses, ∆SBP (P = .082), rSBP (P = .008), and rDBP (P < .001) were of potential prognostic value (P < .10), but ∆DBP was not (P = .96). After adjustment for other clinical and MPI variables, ∆SBP no longer independently predicted mortality (P = .082); only lower rSBP (P = .026) and lower rDBP (P = .045) remained independently prognostic.

Conclusions

In patients undergoing vasodilator stress MPI, only lower resting BP is an independent predictor of mortality along with other clinical and MPI variables; BP response does not appear to add to risk stratification in these patients.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Fletcher GF, Ades PA, Kligfield P, Arena R, Balady GJ, Bittner VA, et al. Exercise standards for testing and training: A scientific statement from the American Heart Association. Circulation 2013;128:873–934.CrossRefPubMed Fletcher GF, Ades PA, Kligfield P, Arena R, Balady GJ, Bittner VA, et al. Exercise standards for testing and training: A scientific statement from the American Heart Association. Circulation 2013;128:873–934.CrossRefPubMed
2.
Zurück zum Zitat Le VV, Mitiku T, Sungar G, Myers J, Froelicher V. The blood pressure response to dynamic exercise testing: A systematic review. Prog Cardiovasc Dis 2008;51:135–60.CrossRefPubMed Le VV, Mitiku T, Sungar G, Myers J, Froelicher V. The blood pressure response to dynamic exercise testing: A systematic review. Prog Cardiovasc Dis 2008;51:135–60.CrossRefPubMed
3.
Zurück zum Zitat Bourque JM, Beller GA. Stress myocardial perfusion imaging for assessing prognosis: an update. JACC Cardiovasc Imaging 2011;4:1305–19.CrossRefPubMed Bourque JM, Beller GA. Stress myocardial perfusion imaging for assessing prognosis: an update. JACC Cardiovasc Imaging 2011;4:1305–19.CrossRefPubMed
4.
Zurück zum Zitat Bax JJ, Delgado V. The importance of heart rate response during myocardial perfusion imaging. J Nucl Cardiol 2014;21:245–7.CrossRefPubMed Bax JJ, Delgado V. The importance of heart rate response during myocardial perfusion imaging. J Nucl Cardiol 2014;21:245–7.CrossRefPubMed
5.
Zurück zum Zitat Lauer MS, Okin PM, Larson MG, Evans JC, Levy D. Impaired heart rate response to graded exercise. Prognostic implications of chronotropic incompetence in the Framingham Heart Study. Circulation 1996;93:1520–6.CrossRefPubMed Lauer MS, Okin PM, Larson MG, Evans JC, Levy D. Impaired heart rate response to graded exercise. Prognostic implications of chronotropic incompetence in the Framingham Heart Study. Circulation 1996;93:1520–6.CrossRefPubMed
6.
Zurück zum Zitat Miller TD. Exercise treadmill test: Estimating cardiovascular prognosis. Cleve Clin J Med 2008;75:424–30.CrossRefPubMed Miller TD. Exercise treadmill test: Estimating cardiovascular prognosis. Cleve Clin J Med 2008;75:424–30.CrossRefPubMed
7.
Zurück zum Zitat Bellam N, Veledar E, Dorbala S, Di Carli MF, Shah S, Eapen D, et al. Prognostic significance of impaired chronotropic response to pharmacologic stress Rb-82 PET. J Nucl Cardiol 2014;21:233–44.CrossRefPubMed Bellam N, Veledar E, Dorbala S, Di Carli MF, Shah S, Eapen D, et al. Prognostic significance of impaired chronotropic response to pharmacologic stress Rb-82 PET. J Nucl Cardiol 2014;21:233–44.CrossRefPubMed
8.
Zurück zum Zitat Dorbala S, Di Carli MF, Beanlands RS, Merhige ME, Williams BA, Veledar E, et al. Prognostic value of stress myocardial perfusion positron emission tomography: Results from a multicenter observational registry. J Am Coll Cardiol 2013;61:176–84.CrossRefPubMed Dorbala S, Di Carli MF, Beanlands RS, Merhige ME, Williams BA, Veledar E, et al. Prognostic value of stress myocardial perfusion positron emission tomography: Results from a multicenter observational registry. J Am Coll Cardiol 2013;61:176–84.CrossRefPubMed
9.
Zurück zum Zitat Dorbala S, Hachamovitch R, Curillova Z, Thomas D, Vangala D, Kwong RY, et al. Incremental prognostic value of gated Rb-82 positron emission tomography myocardial perfusion imaging over clinical variables and rest LVEF. JACC Cardiovasc Imaging 2009;2:846–54.CrossRefPubMedPubMedCentral Dorbala S, Hachamovitch R, Curillova Z, Thomas D, Vangala D, Kwong RY, et al. Incremental prognostic value of gated Rb-82 positron emission tomography myocardial perfusion imaging over clinical variables and rest LVEF. JACC Cardiovasc Imaging 2009;2:846–54.CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat Kay J, Dorbala S, Goyal A, Fazel R, Di Carli MF, Einstein AJ, et al. Influence of sex on risk stratification with stress myocardial perfusion Rb-82 positron emission tomography: Results from the PET (Positron Emission Tomography) Prognosis Multicenter Registry. J Am Coll Cardiol 2013;62:1866–76.CrossRefPubMed Kay J, Dorbala S, Goyal A, Fazel R, Di Carli MF, Einstein AJ, et al. Influence of sex on risk stratification with stress myocardial perfusion Rb-82 positron emission tomography: Results from the PET (Positron Emission Tomography) Prognosis Multicenter Registry. J Am Coll Cardiol 2013;62:1866–76.CrossRefPubMed
11.
Zurück zum Zitat Merhige ME, Breen WJ, Shelton V, Houston T, D’Arcy BJ, Perna AF. Impact of myocardial perfusion imaging with PET and (82)Rb on downstream invasive procedure utilization, costs, and outcomes in coronary disease management. J Nucl Med 2007;48:1069–76.CrossRefPubMed Merhige ME, Breen WJ, Shelton V, Houston T, D’Arcy BJ, Perna AF. Impact of myocardial perfusion imaging with PET and (82)Rb on downstream invasive procedure utilization, costs, and outcomes in coronary disease management. J Nucl Med 2007;48:1069–76.CrossRefPubMed
12.
Zurück zum Zitat Dilsizian V, Bacharach SL, Beanlands RS, Bergmann SR, Delbeke D, Gropler RJ, et al. PET myocardial perfusion and metabolism clinical imaging. J Nucl Cardiol 2009;16:651.CrossRef Dilsizian V, Bacharach SL, Beanlands RS, Bergmann SR, Delbeke D, Gropler RJ, et al. PET myocardial perfusion and metabolism clinical imaging. J Nucl Cardiol 2009;16:651.CrossRef
13.
Zurück zum Zitat Hachamovitch R, Rozanski A, Shaw LJ, Stone GW, Thomson LE, Friedman JD, et al. Impact of ischaemia and scar on the therapeutic benefit derived from myocardial revascularization vs. medical therapy among patients undergoing stress-rest myocardial perfusion scintigraphy. Eur Heart J 2011;32:1012–24.CrossRefPubMed Hachamovitch R, Rozanski A, Shaw LJ, Stone GW, Thomson LE, Friedman JD, et al. Impact of ischaemia and scar on the therapeutic benefit derived from myocardial revascularization vs. medical therapy among patients undergoing stress-rest myocardial perfusion scintigraphy. Eur Heart J 2011;32:1012–24.CrossRefPubMed
14.
Zurück zum Zitat Lozano R, Murray CJL, Lopez AD, Satoh T, Policy WHOGPoEfH. Miscoding and misclassification of ischaemic heart disease mortality 2001. Lozano R, Murray CJL, Lopez AD, Satoh T, Policy WHOGPoEfH. Miscoding and misclassification of ischaemic heart disease mortality 2001.
15.
Zurück zum Zitat D’Amico M, Agozzino E, Biagino A, Simonetti A, Marinelli P. Ill-defined and multiple causes on death certificates: A study of misclassification in mortality statistics. Eur J Epidemiol 1999;15:141–8.CrossRefPubMed D’Amico M, Agozzino E, Biagino A, Simonetti A, Marinelli P. Ill-defined and multiple causes on death certificates: A study of misclassification in mortality statistics. Eur J Epidemiol 1999;15:141–8.CrossRefPubMed
16.
Zurück zum Zitat DeHenauw S, de Smet P, Aelvoet W, Kornitzer M, DeBacker G. Misclassification of coronary heart disease in mortality statistics. Evidence from the WHO-MONICA Ghent-Charleroi Study in Belgium. J Epidemiolo Community Health 1998;52:513–9.CrossRef DeHenauw S, de Smet P, Aelvoet W, Kornitzer M, DeBacker G. Misclassification of coronary heart disease in mortality statistics. Evidence from the WHO-MONICA Ghent-Charleroi Study in Belgium. J Epidemiolo Community Health 1998;52:513–9.CrossRef
17.
Zurück zum Zitat Rhoades DA. Racial misclassification and disparities in cardiovascular disease among American Indians and Alaska Natives. Circulation 2005;111:1250–6.CrossRefPubMed Rhoades DA. Racial misclassification and disparities in cardiovascular disease among American Indians and Alaska Natives. Circulation 2005;111:1250–6.CrossRefPubMed
18.
Zurück zum Zitat Hage FG, Heo J, Franks B, Belardinelli L, Blackburn B, Wang W, et al. Differences in heart rate response to adenosine and regadenoson in patients with and without diabetes mellitus. Am Heart J 2009;157:771–6.CrossRefPubMed Hage FG, Heo J, Franks B, Belardinelli L, Blackburn B, Wang W, et al. Differences in heart rate response to adenosine and regadenoson in patients with and without diabetes mellitus. Am Heart J 2009;157:771–6.CrossRefPubMed
19.
Zurück zum Zitat Hage FG, Dean P, Iqbal F, Heo J, Iskandrian AE. A blunted heart rate response to regadenoson is an independent prognostic indicator in patients undergoing myocardial perfusion imaging. J Nucl Cardiology 2011;18:1086–94.CrossRef Hage FG, Dean P, Iqbal F, Heo J, Iskandrian AE. A blunted heart rate response to regadenoson is an independent prognostic indicator in patients undergoing myocardial perfusion imaging. J Nucl Cardiology 2011;18:1086–94.CrossRef
20.
Zurück zum Zitat Hage FG, Iskandrian AE. Cardiac autonomic denervation in diabetes mellitus. Circulation 2011;4:79–81.PubMed Hage FG, Iskandrian AE. Cardiac autonomic denervation in diabetes mellitus. Circulation 2011;4:79–81.PubMed
21.
22.
Zurück zum Zitat Johnston DL, Daley JR, Hodge DO, Hopfenspirger MR, Gibbons RJ. Hemodynamic responses and adverse effects associated with adenosine and dipyridamole pharmacologic stress testing: A comparison in 2,000 patients. Mayo Clin Proc 1995;70:331–6.CrossRefPubMed Johnston DL, Daley JR, Hodge DO, Hopfenspirger MR, Gibbons RJ. Hemodynamic responses and adverse effects associated with adenosine and dipyridamole pharmacologic stress testing: A comparison in 2,000 patients. Mayo Clin Proc 1995;70:331–6.CrossRefPubMed
23.
Zurück zum Zitat Vasu S, Bandettini WP, Hsu L-Y, Kellman P, Leung S, Mancini C, et al. Regadenoson and adenosine are equivalent vasodilators and are superior than dipyridamole: A study of first pass quantitative perfusion cardiovascular magnetic resonance. J Cardiovasc Magn Reson 2013;15:85.CrossRefPubMedPubMedCentral Vasu S, Bandettini WP, Hsu L-Y, Kellman P, Leung S, Mancini C, et al. Regadenoson and adenosine are equivalent vasodilators and are superior than dipyridamole: A study of first pass quantitative perfusion cardiovascular magnetic resonance. J Cardiovasc Magn Reson 2013;15:85.CrossRefPubMedPubMedCentral
Metadaten
Titel
Prognostic significance of blood pressure response during vasodilator stress Rb-82 positron emission tomography myocardial perfusion imaging
verfasst von
Bradley Witbrodt, MD
Abhinav Goyal, MD, MHS
Anita A. Kelkar, MD
Sharmila Dorbala, MD, MPH
Benjamin J. W. Chow, MD
Marcelo F. Di Carli, MD
Brent A. Williams, PhD
Michael E. Merhige, MD
Daniel S. Berman, MD
Guido Germano, PhD
Robert S. Beanlands, MD
James K. Min, MD
Punitha Arasaratnam, MD
Masoud Sadreddini, MD
Marjolein Lidwine van Velthuijsen, MD
Leslee J. Shaw, PhD
Publikationsdatum
01.12.2017
Verlag
Springer US
Erschienen in
Journal of Nuclear Cardiology / Ausgabe 6/2017
Print ISSN: 1071-3581
Elektronische ISSN: 1532-6551
DOI
https://doi.org/10.1007/s12350-016-0569-1

Weitere Artikel der Ausgabe 6/2017

Journal of Nuclear Cardiology 6/2017 Zur Ausgabe

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.